The DOI matches its Crossref record; 58 of the 59 references it cites were found in a registry or an index.
Oxidative Damage Is the Earliest Event in Alzheimer Disease
Open accessAbstract
Recently, we demonstrated a significant increase of an oxidized nucleoside derived from RNA, 8-hydroxyguanosine (8OHG), and an oxidized amino acid, nitrotyrosine in vulnerable neurons of patients with Alzheimer disease (AD). To determine whether oxidative damage is an early- or end-stage event in the process of neurodegeneration in AD, we investigated the relationship between neuronal 8OHG and nitrotyrosine and histological and clinical variables, i.e. amyloid-beta (A beta) plaques and neurofibrillary tangles (NFT), as well as duration of dementia and apolipoprotein E (ApoE) genotype. Our findings show that oxidative damage is quantitatively greatest early in the disease and reduces with disease progression. Surprisingly, we found that increases in A beta deposition are associated with decreased oxidative damage. These relationships are more significant in ApoE epsilon4 carriers. Moreover, neurons with NFT show a 40%-56% decrease in relative 8OHG levels compared with neurons free of NFT. Our observations indicate that increased oxidative damage is an early event in AD that decreases with disease progression and lesion formation. These findings suggest that AD is associated with compensatory changes that reduce damage from reactive oxygen.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Past and recent studies have demonstrated that oxidative damage is not only an early event in the pathogenesis of AD, occurring before the onset of clinical symptoms but also a factor contributing to the disease progression [17,18,19,20,21].”
From Role of Oxidative Damage in Alzheimer’s Disease and Neurodegeneration: From Pathogenic Mechanisms to Biomarker Discovery (2021) · cites this paper as [19]
Experimental — accuracy not yet measuredIn the citing paper
“In the brains of individuals with AD and preclinical AD (i.e., evidence of Aβ and tau deposition in the brain without any clinical manifestation of the disease), as well as patients with MCI (a mild clinical impairment with no proof of underlying pathology with biomarkers), many oxidative damage products are measured, and numerous investigations have pointed to OS as a key and early player in the”
From Role of Oxidative Damage in Alzheimer’s Disease and Neurodegeneration: From Pathogenic Mechanisms to Biomarker Discovery (2021) · cites this paper as [19]
In the citing paper
“In the AD brain, mitochondria can be sources of ROS and also the target of OS, especially mitochondrial DNA (mtDNA) is susceptible to oxidative damage [19,53,63].”
From Role of Oxidative Damage in Alzheimer’s Disease and Neurodegeneration: From Pathogenic Mechanisms to Biomarker Discovery (2021) · cites this paper as [19]
In the citing paper
“Oxidative damage to RNA in EC, hippocampus, subiculum, and temporal neocortex of subjects with AD has been described. The levels of 8-OHdG increase early before pathological changes occur, and this can explain that the selective vulnerability of neurons in the EC during AD may be related to the vulnerability of these particular neurons to oxidative damage [19].”
From Role of Oxidative Damage in Alzheimer’s Disease and Neurodegeneration: From Pathogenic Mechanisms to Biomarker Discovery (2021) · cites this paper as [19]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Theory and Practice of Histological Techniques
Bancroft, J. D., & Gamble, M. (1990) · Cited by 6,948
Mirra, S. S., Heyman, A., McKeel, D., Sumi, S. M., Crain, B. J., Brownlee, L. M., Vogel, F. S., Hughes, J. P., Belle, G. V., Berg, L., et al. (1991) · Neurology · doi:10.1212/wnl.41.4.479 · Cited by 4,961
Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI.
Hixson, J., & Vernier, D. (1990) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)43176-1 · Cited by 2,933
Consortium to Establish a Registry for Alzheimer's Disease (CERAD)
Fillenbaum, G., & Heyman, A. (2002) · doi:10.1002/0470846410.ch42(iii · Cited by 2,859
Diagnosis of Alzheimer's Disease
Khachaturian, Z. S. (1985) · Archives of Neurology · doi:10.1001/archneur.1985.04060100083029 · Cited by 2,499
Hydrogen peroxide mediates amyloid β protein toxicity
Behl, C. (1994) · Cell · doi:10.1016/0092-8674(94)90131-7 · Cited by 2,074
Mitochondrial abnormalities in Alzheimer's disease
Hirai, K., Aliev, G., Nunomura, A., Fujioka, H., Russell, R. L., Atwood, C. S., Johnson, A. B., Kress, Y., Vinters, H. V., Tabaton, M., et al. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-09-03017.2001 · Cited by 1,367
Self-citationReiman, E. M., Caselli, R. J., Yun, L. S., Chen, K., Bandy, D., Minoshima, S., Thibodeau, S. N., & Osborne, D. (1996) · New England Journal of Medicine · doi:10.1056/nejm199603213341202 · Cited by 1,366
Strittmatter, W. J., Weisgraber, K. H., Huang, D. Y., Dong, L. M., Salvesen, G. S., Pericak-Vance, M., Schmechel, D., Saunders, A. M., Goldgaber, D., & Roses, A. D. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.17.8098 · Cited by 1,363
Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease.
Smith, C. D., Carney, J. M., Starke-Reed, P. E., Oliver, C. N., Stadtman, E. R., Floyd, R. A., & Markesbery, W. R. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.23.10540 · Cited by 1,296
Research works printed but not linked: 2
- Smith, 1998, ApoE: Isoform specific antioxidant activity [abstract], Neurobiol Aging, 19, S222
- Nunomura, 2000, Increasing amyloid ß 42 deposition is associated with decreasing neuronal RNA oxidation in Down's syndrome and familial Alzheimer's disease [abstract], Brain pathol, 10, 783
Cited by
Sorted by citations
Items 601–700 of 1,005
Mnatsakanyan, N., & Jonas, E. A. (2020) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2020.05.013 · Cited by 76
Amelioration of the Alzheimer's Disease Phenotype by Absence of 12/15-Lipoxygenase
Yang, H., Zhuo, J., Chu, J., Chinnici, C. M., & Praticò, D. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.04.010 · Cited by 75
Lovell, M. A., Xiong, S., Ganna Lyubartseva, A., & Markesbery, W. R. (2009) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2009.03.008 · Cited by 75
The Dual Role of Hepcidin in Brain Iron Load and Inflammation
Vela, D. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00740 · Cited by 75
Munawara, U., Catanzaro, M., Xu, W., Tan, C., Hirokawa, K., Bosco, N., Dumoulin, D., Khalil, A., Larbi, A., Lévesque, S., et al. (2021) · Immunity & Ageing · doi:10.1186/s12979-021-00236-x · Cited by 74
Shamsi, A., Shahwan, M. J., Khan, M. S., Husain, F. M., Alhumaydhi, F. A., Aljohani, A. S. M., Rehman, M. T., Hassan, M. I., & Islam, A. (2021) · ACS Omega · doi:10.1021/acsomega.1c00527 · Cited by 76
Valverde-Salazar, V., Ruiz-Gabarre, D., & García‐Escudero, V. (2023) · Antioxidants · doi:10.3390/antiox12071460 · Cited by 76
Pytharopoulou, S., Sazakli, E., Grintzalis, K., Georgiou, C. D., Leotsinidis, M., & Kalpaxis, D. L. (2008) · Aquatic Toxicology · doi:10.1016/j.aquatox.2008.05.013 · Cited by 74
Han, H. J., Long, H., Wang, H., Wang, J., Zhang, Y., & Wang, Z. (2004) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00199.2003 · Cited by 74
Functional impairment in aged rats chronically exposed to human range dietary aluminum equivalents
Walton, J. R. (2008) · NeuroToxicology · doi:10.1016/j.neuro.2008.11.012 · Cited by 74
MicroRNA: A matter of life or death
Wang, Z. (2010) · World Journal of Biological Chemistry · doi:10.4331/wjbc.v1.i4.41 · Cited by 74
Elharram, A., Czegledy, N. M., Golod, M., Milne, G. L., Pollock, E. D., Bennett, B. M., & Shchepinov, M. S. (2017) · FEBS Journal · doi:10.1111/febs.14291 · Cited by 74
Sotolongo, K., Ghiso, J. A., & Rostagno, A. A. (2020) · Alzheimer s Research & Therapy · doi:10.1186/s13195-019-0578-9 · Cited by 74
A Review of Oxidative Stress Products and Related Genes in Early Alzheimer’s Disease
Cioffi, F., Adam, R. H. I., Bansal, R., & Broersen, K. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-210497 · Cited by 73
Díaz, A., Limón, I. D., Chávez, R., Zenteno, E., & Guevara, J. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-111979 · Cited by 73
Lee, H., Ueda, M., Zhu, X., Perry, G. L., & Smith, M. A. (2006) · Journal of Neuroscience Research · doi:10.1002/jnr.21072 · Cited by 73
Self-citationFunctionalized nanosystems for targeted mitochondrial delivery
Durazo, S. A., & Kompella, U. B. (2011) · Mitochondrion · doi:10.1016/j.mito.2011.11.001 · Cited by 73
Causes versus effects: the increasing complexities of Alzheimer’s disease pathogenesis
Mondragón‐Rodríguez, S., Basurto‐Islas, G., Lee, H., Perry, G. L., Zhu, X., Castellani, R. J., & Smith, M. A. (2010) · Expert Review of Neurotherapeutics · doi:10.1586/ern.10.27 · Cited by 73
Self-citationPerry, G. L., Taddeo, M. A., Nunomura, A., Zhu, X., Zenteno‐Savín, T., Drew, K. L., Shimohama, S., Ávila, J., Castellani, R. J., & Smith, M. A. (2002) · Comparative Biochemistry and Physiology Part C Toxicology & Pharmacology · doi:10.1016/s1532-0456(02)00119-9 · Cited by 73
Self-citationDumont, M., Ho, D. J., Calingasan, N. Y., Xu, H., Gibson, G. E., & Beal, M. F. (2009) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2009.07.008 · Cited by 73
Aβ42 neurotoxicity in primary co-cultures: effect of apoE isoform and Aβ conformation
Manelli, A. M., Bulfinch, L. C., Sullivan, P. M., & LaDu, M. J. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.05.024 · Cited by 72
Role of mitochondrial-mediated signaling pathways in Alzheimer disease and hypoxia
Carvalho, C., Correia, S. C., Santos, R. X., Cardoso, S., Moreira, P. I., Clark, T. A., Zhu, X., Smith, M. A., & Perry, G. (2009) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-009-9247-1 · Cited by 72
Self-citationBrain sterol dysregulation in sporadic AD and MCI: relationship to heme oxygenase‐1
Hascalovici, J., Vaya, J., Khatib, S., Holcroft, C., Zukor, H., Song, W., Arvanitakis, Z., Bennett, D. A., & Schipper, H. M. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06213.x · Cited by 73
Wung, J. K., Perry, G. L., Kowalski, A. J., Harris, P. L. R., Bishop, G. M., Trivedi, M. A., Johnson, S. C., Smith, M. A., Denhardt, D. T., & Atwood, C. (2007) · Current Alzheimer Research · doi:10.2174/156720507779939869 · Cited by 72
Self-citationPruccoli, L., Morroni, F., Sita, G., Hrelia, P., & Tarozzi, A. (2020) · Antioxidants · doi:10.3390/antiox9060551 · Cited by 72
Antioxidant protection and neurodegenerative disease: The role of amyloid-β and tau
Castellani, R. J., Lee, H., Perry, G. L., & Smith, M. A. (2006) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/153331750602100213 · Cited by 72
Self-citationOxidative stress and disturbed glutamate transport in spinal muscular atrophy
Hayashi, M., Araki, S., Arai, N., Kumada, S., Itoh, M., Tamagawa, K., Oda, M., & Morimatsu, Y. (2002) · Brain and Development · doi:10.1016/s0387-7604(02)00103-1 · Cited by 72
Obesity and Diabetes Mediated Chronic Inflammation: A Potential Biomarker in Alzheimer’s Disease
Khan, M. S. H., & Hegde, V. K. (2020) · Journal of Personalized Medicine · doi:10.3390/jpm10020042 · Cited by 71
Modifiable, Non-Modifiable, and Clinical Factors Associated with Progression of Alzheimer’s Disease
Loeffler, D. A. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-201182 · Cited by 71
Reassessment of Pioglitazone for Alzheimer’s Disease
Saunders, A. M., Burns, D. K., & Gottschalk, W. K. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.666958 · Cited by 71
Ohno, M., Oka, S., & Nakabeppu, Y. (2009) · Methods in molecular biology · doi:10.1007/978-1-59745-521-3_13 · Cited by 71
Isobe, C., Abe, T., & Terayama, Y. (2009) · Journal of Neurology · doi:10.1007/s00415-009-5333-x · Cited by 71
Jha, M. K., Jeon, S., & Suk, K. (2012) · Current Neuropharmacology · doi:10.2174/157015912804143586 · Cited by 71
Anthocyanins Potentially Contribute to Defense against Alzheimer’s Disease
Afzal, M., Redha, A., & Al-Hasan, R. H. (2019) · Molecules · doi:10.3390/molecules24234255 · Cited by 71
The Role of Copper in Tau-Related Pathology in Alzheimer’s Disease
Zubčić, K., Hof, P. R., Šimić, G., & Jembrek, M. J. (2020) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2020.572308 · Cited by 71
Oxidative stress induces axonal beading in cultured human brain tissue
Roediger, B., & Armati, P. J. (2003) · Neurobiology of Disease · doi:10.1016/s0969-9961(03)00038-x · Cited by 71
Pinho, T. S., Correia, S. C., Perry, G., Ambrósio, A. F., & Moreira, P. I. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.10.037 · Cited by 70
Self-citationNear infrared light mitigates cerebellar pathology in transgenic mouse models of dementia
Purushothuman, S., Johnstone, D. M., Nandasena, C., van Eersel, J., Ittner, L. M., Mitrofanis, J., & Stone, J. (2015) · Neuroscience Letters · doi:10.1016/j.neulet.2015.02.037 · Cited by 70
Kanninen, K. M., White, A. R., Koıstınaho, J., & Malm, T. (2011) · International Journal of Alzheimer s Disease · doi:10.4061/2011/985085 · Cited by 70
Glutamate metabolism in HIV-1 infected macrophages: Role of HIV-1 Vpr
Datta, P. K., Deshmane, S. L., Khalili, K., Merali, S., Gordon, J. C., Fecchio, C., & Barrero, C. A. (2016) · Cell Cycle · doi:10.1080/15384101.2016.1190054 · Cited by 70
Apelin, a promising target for Alzheimer disease prevention and treatment
Masoumi, J., Abbasloui, M., Parvan, R., Mohammadnejad, D., Pavon‐Djavid, G., Barzegari, A., & Abdolalizadeh, J. (2018) · Neuropeptides · doi:10.1016/j.npep.2018.05.008 · Cited by 70
Zhang, Y., Yang, X., Wang, S., & Song, S. (2019) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.9b03793 · Cited by 70
Nonselenium Glutathione Peroxidase in Human Brain
Power, J. H. T., Shannon, J. M., Blumbergs, P. C., & Gai, W. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64249-6 · Cited by 70
Increased isoprostane and prostaglandin are prominent in neurons in Alzheimer disease
Casadesús, G., Smith, M. A., Basu, S., Hua, J., Capobianco, D. E., Siedlak, S. L., Zhu, X., & Perry, G. L. (2007) · Molecular Neurodegeneration · doi:10.1186/1750-1326-2-2 · Cited by 70
Self-citationDecourt, B., D’Souza, G. X., Shi, J., Ritter, A., Suazo, J., & Sabbagh, M. N. (2022) · Aging and disease · doi:10.14336/ad.2021.0529 · Cited by 69
Alzheimer’s Disease Pathologic Cascades: Who Comes First, What Drives What
Swerdlow, R. H. (2011) · Neurotoxicity Research · doi:10.1007/s12640-011-9272-9 · Cited by 69
Peptides as Potential Therapeutics for Alzheimer’s Disease
Ribarič, S. (2018) · Molecules · doi:10.3390/molecules23020283 · Cited by 69
Smith, M. (2002) · Neurochemistry International · doi:10.1016/s0197-0186(01)00123-1 · Cited by 69
Self-citationHan, J., Park, H.-J., Maharana, C., Gwon, A., Park, J., Baek, S. H., Bae, H., Cho, Y., Kim, H. K., Sul, J. H., et al. (2021) · Theranostics · doi:10.7150/thno.59776 · Cited by 68
Everett, J. L., Céspedes, E., Shelford, L. R., Exley, C., Collingwood, J. F., Dobson, J., van der Laan, G., Jenkins, C., Arenholz, E., & Telling, N. D. (2014) · Inorganic Chemistry · doi:10.1021/ic402406g · Cited by 68
Elmlinger, M. W., Kriebel, M., & Ziegler, D. (2011) · NeuroMolecular Medicine · doi:10.1007/s12017-011-8157-7 · Cited by 68
Age-Related Neurodegeneration and Memory Loss in Down Syndrome
Lockrow, J. P., Fortress, A. M., & Granholm, A. (2012) · Current Gerontology and Geriatrics Research · doi:10.1155/2012/463909 · Cited by 68
Amyloid-β25–35 impairs memory and increases NO in the temporal cortex of rats
Limón, I. D., Díaz, A., Mendieta, L., Chamorro, G., Espinosa, B., Zenteno, E., & Guevara, J. (2008) · Neuroscience Research · doi:10.1016/j.neures.2008.11.006 · Cited by 68
Puentes-Díaz, N., Chaparro, D., Morales-Morales, D., Flores-Gaspar, A., & Alí-Torres, J. (2023) · ACS Omega · doi:10.1021/acsomega.2c06939 · Cited by 67
Physiological Role of Amyloid Beta in Neural Cells: The Cellular Trophic Activity
Cárdenas‐Aguayo, M. D. C., Silva‐Lucero, M., Cortés-Ortiz, M., Jimnez-Ramos, B., Gomez‐Virgilio, L., Ramrez-Rodrguez, G., Arroyo, E. V., Fiorentino-Prez, R., Garca, U., Luna-Muoz, J., et al. (2014) · InTech eBooks · doi:10.5772/57398 · Cited by 67
The amyloid hypothesis: let sleeping dogmas lie?
Bishop, G. M., & Robinson, S. R. (2002) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00050-7 · Cited by 67
Surface Plasmon Resonance and Nuclear Magnetic Resonance Studies of ABAD−Aβ Interaction
Yan, Y., Liu, Y., Sorci, M., Belfort, G., Lustbader, J. W., Yan, S. S., & Wang, C. (2007) · Biochemistry · doi:10.1021/bi061314n · Cited by 67
Biochemical Markers and Risk Factors of Alzheimers Disease
Flirski, M., & Sobów, T. (2005) · Current Alzheimer Research · doi:10.2174/1567205052772704 · Cited by 67
Pathogenesis of Alzheimer’s Disease
Castellani, R. J., & Perry, G. L. (2014) · Springer eBooks · doi:10.1007/978-1-4614-5836-4_162 · Cited by 67
Self-citationChen, T., Tan, J., Wan, Z., Zou, Y., Afewerky, H. K., Zhang, Z., & Zhang, T. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18122507 · Cited by 67
A New Discovery of MicroRNA-455-3p in Alzheimer’s Disease
Kumar, S., & Reddy, P. H. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-190583 · Cited by 67
Oxidative Stress and Neuronal Adaptation in Alzheimer Disease: The Role of SAPK Pathways
Zhu, X., Raina, A. K., Lee, H., Chao, M. P., Nunomura, A., Tabaton, M., Petersen, R. B., Perry, G. L., & Smith, M. A. (2003) · Antioxidants and Redox Signaling · doi:10.1089/152308603770310220 · Cited by 67
Self-citationAscorbic acid protects SH-SY5Y neuroblastoma cells from apoptosis and death induced by β-amyloid
Huang, J., & May, J. M. (2006) · Brain Research · doi:10.1016/j.brainres.2006.04.047 · Cited by 67
Tan, J.-L., Li, Q.-X., Ciccotosto, G. D., Crouch, P. J., Culvenor, J. G., White, A. R., & Evin, G. (2013) · PLoS ONE · doi:10.1371/journal.pone.0061246 · Cited by 66
Mukhopadhyay, S., & Banerjee, D. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-215065 · Cited by 66
Changes in Oxidative Damage, Inflammation and [NAD(H)] with Age in Cerebrospinal Fluid
Guest, J., Grant, R., Mori, T. A., & Croft, K. D. (2014) · PLoS ONE · doi:10.1371/journal.pone.0085335 · Cited by 66
“Considerable evidence now indicates that both inflammation and oxidative stress contribute to the development of various neuropathologies including Alzheimer’s and Parkinson’s disease [14,16,23].”
BackgroundAlkhalifa, A. E., Alkhalifa, O., Durdanovic, I., Ibrahim, D. R., & Maragkou, S. (2025) · Journal of Dementia and Alzheimer's Disease · doi:10.3390/jdad2020017 · Cited by 66
Role of Oxidative RNA Damage in Chronic-Degenerative Diseases
Fimognari, C. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2015/358713 · Cited by 66
Gu, M., Bode, D. C., & Viles, J. H. (2018) · Scientific Reports · doi:10.1038/s41598-018-33935-5 · Cited by 66
Peptidyl-Prolyl Cis/Trans Isomerase Pin1 and Alzheimer’s Disease
Wang, L., Zhou, Y., Chen, D., & Lee, T. H. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00355 · Cited by 66
Amyloid‐β in Alzheimer's disease: the horse or the cart? Pathogenic or protective?
Lee, H., Castellani, R. J., Zhu, X., Perry, G. L., & Smith, M. A. (2005) · International Journal of Experimental Pathology · doi:10.1111/j.0959-9673.2005.00429.x · Cited by 66
Self-citationPerspectives on the Amyloid-β Cascade Hypothesis
Lee, H., Casadesús, G., Zhu, X., Joseph, J. A., Perry, G. L., & Smith, M. A. (2004) · Journal of Alzheimer s Disease · doi:10.3233/jad-2004-6205 · Cited by 66
Self-citationGibson, G. E., & Huang, H. (2004) · Journal of Bioenergetics and Biomembranes · doi:10.1023/b:jobb.0000041764.45552.f3 · Cited by 66
Fawcett, J. R., Bordayo, E. Z., Jackson, K., Liu, H., Peterson, J., Svitak, A. L., & Frey, W. H. (2002) · Brain Research · doi:10.1016/s0006-8993(02)02981-5 · Cited by 66
BRCA1 May Modulate Neuronal Cell Cycle Re-Entry in Alzheimer Disease
Evans, T. A., Raina, A. K., Delacourte, A., Aprelikova, O. N., Lee, H., Zhu, X., Perry, G. L., & Smith, M. A. (2007) · International Journal of Medical Sciences · doi:10.7150/ijms.4.140 · Cited by 66
Self-citationGonadotropin-Releasing Hormone Receptor System: Modulatory Role in Aging and Neurodegeneration
Wang, L., Chadwick, W., Park, S. S., Zhou, Y., Silver, N., Martin, B., & Maudsley, S. R. (2010) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152710793361559 · Cited by 66
Mitochondrial Importance in Alzheimer’s, Huntington’s and Parkinson’s Diseases
Correia, S. C., Santos, R. X., Perry, G. L., Zhu, X., Moreira, P. I., & Smith, M. A. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-0653-2_16 · Cited by 65
Self-citationSources and triggers of oxidative damage in neurodegeneration
Angelova, P. R. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.07.003 · Cited by 67
Wang, S.-W., Yang, S., Liu, W., Zhang, Y., Xu, P., Wang, T., Ling, T.-J., & Liu, R. (2015) · Behavioural Brain Research · doi:10.1016/j.bbr.2015.09.003 · Cited by 65
The Amyloid Paradox: Amyloid‐β‐Metal Complexes can be Neurotoxic and Neuroprotective
Bishop, G. M., & Robinson, S. R. (2004) · Brain Pathology · doi:10.1111/j.1750-3639.2004.tb00089.x · Cited by 65
Antioxidant Activity of Galantamine and Some of its Derivatives
Tsvetkova, D. D., Obreshkova, D. P., Zheleva‐Dimitrova, D., & Saso, L. (2013) · Current Medicinal Chemistry · doi:10.2174/09298673113209990148 · Cited by 65
Moreira, P. I., Sayre, L. M., Zhu, X., Nunomura, A., Smith, M. A., & Perry, G. L. (2009) · Methods in molecular biology · doi:10.1007/978-1-60327-029-8_25 · Cited by 65
Self-citationNtsapi, C., & Loos, B. (2016) · Experimental Gerontology · doi:10.1016/j.exger.2016.07.014 · Cited by 65
Oguchi, T., Ono, R., Tsuji, M., Shozawa, H., Somei, M., Inagaki, M., Mori, Y., Yasumoto, T., Ono, K., & Kiuchi, Y. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00337 · Cited by 65
Sleep and circadian rhythm disruption and stress intersect in Alzheimer's disease
Phan, T., & Malkani, R. G. (2018) · Neurobiology of Stress · doi:10.1016/j.ynstr.2018.10.001 · Cited by 66
Mitochondrially-targeted treatment strategies
Bozi, L. H. M., Campos, J. C., Zambelli, V. O., Ferreira, N. D., & Ferreira, J. C. B. (2019) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2019.100836 · Cited by 67
Gibson, G. E. (2002) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)00802-x · Cited by 65
Aliyev, A., Chen, S. G., Seyidova, D., Smith, M. A., Perry, G. L., de la Torre, J., & Aliev, G. (2004) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2004.11.040 · Cited by 65
Self-citationIron Pathophysiology in Alzheimer’s Diseases
Wang, T., Xu, S.-F., Fan, Y.-G., Li, L.-B., & Guo, C. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-9589-5_5 · Cited by 64
Choroid Plexus in Alzheimer’s Disease—The Current State of Knowledge
Gião, T., Teixeira, T., Almeida, M. R., & Cardoso, I. (2022) · Biomedicines · doi:10.3390/biomedicines10020224 · Cited by 64
Gallagher, J. J., Finnegan, M. E., Grehan, B., Dobson, J., Collingwood, J. F., & Lynch, M. A. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-110614 · Cited by 64
Transgenic Mouse Models of Alzheimer’s Disease: Behavioral Testing and Considerations
Bryan, K. J., Lee, H., Perry, G. L., Smith, M. A., & Casadesús, G. (2009) · Europe PMC (PubMed Central) · Cited by 64
Self-citationOxidative Mechanisms of Brain Dysfunction During Sepsis
Dal‐Pizzol, F., Ritter, C., Cassol-Jr, O. J., Rezin, G. T., Petronilho, F. C., Zugno, A. I., Quevedo, J., & STRECK, E. L. (2009) · Neurochemical Research · doi:10.1007/s11064-009-0043-4 · Cited by 64
Transferrin and HFE genes interact in Alzheimer's disease risk: the Epistasis Project
Lehmann, D. J., Schuur, M., Warden, D. R., Hammond, N., Belbin, O., Kölsch, H., Lehmann, M. G., Wilcock, G. K., Brown, K. S., Kehoe, P. G., et al. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.07.018 · Cited by 64
Fridlich, R., Delalande, F., Jaillard, C., Lu, J., Poidevin, L., Cronin, T., Perrocheau, L., Millet-Puel, G., Niepon, M.-L., Poch, O., et al. (2009) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m800406-mcp200 · Cited by 64
Cu(II) interaction with amyloid-β peptide: A review of neuroactive mechanisms in AD brains
Lin, C., Huang, H., & Jiang, Z.-F. (2010) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2010.06.003 · Cited by 64
Tartaglione, A. M., Venerosi, A., & Calamandrei, G. (2015) · Current topics in behavioral neurosciences · doi:10.1007/7854_2015_416 · Cited by 64
Early life exposure to lead (Pb) and changes in DNA methylation: relevance to Alzheimer’s disease
Bihaqi, S. W. (2019) · Reviews on Environmental Health · doi:10.1515/reveh-2018-0076 · Cited by 64
Jha, M. K., Jeon, S., & Suk, K. (2012) · Current Neuropharmacology · doi:10.2174/157015912804499528 · Cited by 64
Potashkin, J. A., & Meredith, G. E. (2006) · Antioxidants and Redox Signaling · doi:10.1089/ars.2006.8.144 · Cited by 64
Metadata
- Authors
- Nunomura, A., Perry, G., Aliev, G., Hirai, K., Takeda, A., Balraj, E. K., Jones, P. K., Ghanbari, H., Wataya, T., Shimohama, S., Chiba, S., Atwood, C. S., Petersen, R. B., & Smith, M. A.
- Affiliations
- Asahikawa Medical University (JP)
- Case Western Reserve University (US)
- Takeda (Japan) (JP)
- Sensei Biotherapeutics (United States) (US)
- Kyoto University (JP)
- Corresponding author
- Nunomura, Akihiko
- ORCID
- Venue
- Journal of Neuropathology & Experimental Neurology
- Publisher
- Oxford University Press (OUP)
- Published
- 2001-08
- Volume
- 60
- Issue
- 8
- Pages
- 759-767
- ISSN
- 0022-3069 (ISSN-L)
- 1554-6578
- OpenAlex
- W1542215809
- Cited by
- 1,885
- References
- 59
- Citations by year
- 2026: 46 · 2025: 31 · 2024: 52 · 2023: 61 · 2022: 80 · 2021: 98 · 2020: 86 · 2019: 82 · 2018: 69 · 2017: 73 · 2016: 70 · 2015: 83 · 2014: 86 · 2013: 86 · 2012: 104
- FWCI
- 33.08
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Neuropathology & Experimental Neurology (publishedVersion)
- PubMed (publishedVersion)
- Asahikawa Medical University Collection and Research (Asahikawa Medical University) (submittedVersion)
- Institutional Repositories DataBase (IRDB) (submittedVersion)
- Funders
- Alzheimer's Association
- National Institutes of Health (5r01ag009287-08, AG09287)
- Japan Society for the Promotion of Science (12670918)
- National Institute on Aging (AG-14249, R01AG014249, AG 09287)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- Alzheimer's disease, oxidative damage, 8-hydroxyguanosine, nitrotyrosine, amyloid plaques, neurofibrillary tangles, APOE ε4, disease progression, neurodegeneration, reactive oxygen species, RNA oxidation
- MeSH terms
- Aged, Alzheimer Disease, Apolipoproteins E, Brain, Female, Genotype, Guanosine, Heterozygote, Humans, Male, Middle Aged, Neurons, Tyrosine, Amyloid beta-Peptides, Neurofibrillary Tangles, Oxidative Stress, Disease Progression, Plaque, Amyloid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
